BioCryst: 3Q Earnings Snapshot

November 6, 2019 GMT

DURHAM, N.C. (AP) _ BioCryst Pharmaceuticals Inc. (BCRX) on Wednesday reported a loss of $37.6 million in its third quarter.

On a per-share basis, the Durham, North Carolina-based company said it had a loss of 34 cents.

The results fell short of Wall Street expectations. The average estimate of five analysts surveyed by Zacks Investment Research was for a loss of 31 cents per share.

The drugmaker posted revenue of $1.8 million in the period, also missing Street forecasts. Four analysts surveyed by Zacks expected $4.5 million.

The company’s shares closed at $2.03. A year ago, they were trading at $7.93.


This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on BCRX at https://www.zacks.com/ap/BCRX